Herpes Zoster Wound Pain: What to Do When First-Line Analgesics Do Not Achieve Adequate Relief

Clinical Scenario

This protocol addresses herpes zoster-associated nociceptive pain — the acute wound pain arising directly from the zoster lesion. Analgesic treatment is guided by pain intensity on a validated scale (VAS or NRS, 0–10), following the WHO pain relief ladder.

First-Line Treatment — Insufficient Response

When WHO Step 1 therapy — non-opioid analgesics (acetaminophen, metamizole, or NSAIDs such as ibuprofen, diclofenac, naproxen, or selective COX-2 inhibitors) — has not reduced pain to a level tolerable for the patient on the VAS/NRS scale, escalation to the next treatment step is indicated.

Next Treatment Step (Partial Overview)

For moderate pain intensity (WHO Step 2), the approach involves a combination of a non-opioid analgesic with a mild opioid. The specific agent selection and regimen details are set out in the full structured protocol — only a partial indication is given here.

Treatment Goal

Optimal pain relief, or at minimum pain reduction to a level tolerable for the patient, as assessed on a validated pain intensity scale (VAS or NRS, 0–10).

Instant Access to Structured Evidence-Based Regimens

References

DOI: 10.1111/ddg.14013

Analgesic treatment of nociceptive pain based on the WHO's pain relief ladder is recommended (Figure 2).

The treatment goal with respect to herpes zoster-associated pain should be optimal pain relief or at least pain reduction down to a level tolerable for the patient.

View source ↗